It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
...research shows that influenza epidemics are associated with a rise in deaths from heart disease and that flu can actually trigger the heart attacks that result in death.
Researchers believe that flu causes an acute and severe inflammation in the body, which, in some patients, can destabilise atherosclerotic plaques  in coronary arteries and cause heart attacks.
..."Most people develop atherosclerotic lesions in their coronary arteries in early childhood and these lesions grow over time.
In a large matched cohort study of 76,232 patients, moderate use of statins was associated with an 83% reduction in the risk of death from COPD, they reported in the April issue of CHEST.
Use of statins also was linked to a 40% reduced risk of death from pneumonia or flu, according to Floyd Frost, Ph.D., of the Lovelace Respiratory Research Institute here, and colleagues.
The study provided additional evidence that statins, in addition as lowering LDL levels, also can modulate the immune system - a property that may be important in the event of a new flu pandemic, Dr. Frost and colleagues said.
The new study supports a theory proposed last year that statin drugs might help patients with H5N1 avian influenza, which some studies suggest kills by causing an immune system overreaction called a cytokine storm.
"This study found a dramatically reduced risk of death from COPD among statin users and a significantly reduced risk of death from influenza/pneumonia," the researchers wrote in their report, published in the journal Chest.
In 2006, researchers in Canada reported that statins act against sepsis, a dangerous blood infection, and a 2005 study found the death rate was 64 percent lower in pneumonia patients who had been taking statins.
WASHINGTON (Reuters) - People who use statin drugs are less likely to die of influenza and chronic bronchitis, according to a study that shows yet another unexpected benefit of the cholesterol-lowering medications.
Experts say a pandemic of some sort of influenza is inevitable.
Experts generally agree that an effective vaccine would take months to formulate and perhaps years to make enough doses to cover the world. There is also a shortage of antiviral drugs.
Researchers in New Mexico say moderate statin use is linked to a reduced risk of death from the flu and chronic lung disease.
A study of 76,232 patients showed moderate statin use was associated with an 83 percent reduction in risk of death from chronic pulmonary disease, Medpage Today reported on Tuesday. Use of statins was also associated with a 40 percent reduction in death from pneumonia or influenza.
People who use statin drugs are less likely to die of influenza and chronic bronchitis, according to research that shows yet another unexpected benefit of the cholesterol-lowering medications.
The study of more than 76,000 people showed that those who had taken statins for at least 90 days had a much lower risk of dying from chronic obstructive pulmonary disease, or COPD, the technical name for emphysema and chronic bronchitis.
Patients on statins also had a lower risk of dying from influenza or pneumonia, the researchers reported in the April issue of the journal Chest.
Originally posted by hachiban08
im not too knowledgeable on statins, what r they? r they prescription only?
Any of a group of drugs that lower the amount of cholesterol and certain fats in the blood. Statins inhibit a key enzyme that helps make cholesterol. Statin drugs are being studied in the prevention and treatment of cancer.
Women younger than 65 years with certain chronic medical conditions experience substantial morbidity and mortality from acute cardiopulmonary events during influenza season.
...Vanderbilt University Medical Center researchers report that women under the age of 65 with certain chronic medical conditions experience substantial morbidity and mortality from acute cardiopulmonary events during influenza season each year. These chronic conditions include cardiac or pulmonary disease, diabetes, malignancy, chronic renal disease and HIV infection.
While the vast majority - between 60-90 percent - of people who die during influenza season are 65 years or older, nearly three quarters of pneumonia- and influenza-associated hospitalizations occur among people younger than 65.
...(Aspirin) was developed as a painkiller and was mainly marketed as a headache medication or to treat the aches and pains of cold and flu. It takes fairly high doses for Aspirin to relieve pain.
What else does Aspirin do?
In low doses, it can help slow down the formation of blood clots. This can be useful for people at risk of stroke or heart attack. By the early 1980s, Aspirin began to be marketed as more than just a headache pill.
According to Health Canada, Aspirin is "indicated for the relief of pain, fever and inflammation of a variety of conditions such as influenza, common cold, low back and neck pain, dysmenorrhea, headache, toothache, sprains and strains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, injuries, following surgical and dental procedures."
Based on its ability to thin the blood, Health Canada says Aspirin is also indicated for reducing the risk of:
* A first non-fatal heart attack in people deemed at risk by their physicians. The agency notes there's no evidence Aspirin will help ward off a first heart attack that is fatal.
* Venous thromboembolism (blood clots) after total hip replacement.
* Deep vein thrombosis — so called "Economy Class Syndrome" — the formation of blood clots in deep veins. The name was coined after a woman died from a blood clot after a long flight in a cramped seat. Mixed research
Over the past few years, studies have suggested ASA may also help reduce the risk of:
* Colorectal cancer.
* A common form of breast cancer.
* Pre-eclampsia, a pregnancy disorder.